Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review

Classical Hodgkin lymphoma (cHL) is the most common type of HL that occurs mainly in people aged between 15–30 and over 55 years. Although its general prognosis is favorable, 10%–30% of patients with cHL will ultimately develop relapsed or refractory disease (r/r cHL). Improving the cure rate of r/r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yujie, Xing, Zhichao, Mi, Li, Li, Zhihui, Zhu, Jingqiang, Wei, Tao, Wu, Wenshuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344040/
https://www.ncbi.nlm.nih.gov/pubmed/35928877
http://dx.doi.org/10.3389/fonc.2022.929012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344040/
https://www.ncbi.nlm.nih.gov/pubmed/35928877
http://dx.doi.org/10.3389/fonc.2022.929012

Ejemplares similares